Viewing StudyNCT00180895



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00180895
Status: TERMINATED
Last Update Posted: 2006-09-11
First Post: 2005-09-12

Brief Title: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHLL3ALL
Sponsor: Gustave Roussy Cancer Campus Grand Paris
Organization: Gustave Roussy Cancer Campus Grand Paris

Conditions & Keywords Data

Conditions:
Name
Burkitt Lymphoma
Keywords:
Name View
Children View
Burkitt lymphoma View
B-cell non Hodgkin lymphoma View
B-cell ALL View
Refractory View
Relapse View
Rituximab View